Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Singleron (Nanjing) Biotechnologies Ltd. has 1 pending office action in Biotechnology & Pharmaceuticals. The record contains 1 distinct examiner and 1 distinct art unit, so prosecution is concentrated in one channel.
PARISI, JESSICA DANIELLE is the busiest examiner and handles the pending matter. Counsel can focus monitoring and response preparation on that examiner’s examination approach.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PARISI, JESSICA DANIELLE | 1 | 75.0% | +33.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17996196 | A METHOD FOR DETECTION OF WHOLE TRANSCRIPTOME IN SINGLE CELLS | PARISI, JESSICA DANIELLE | 126d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17996196 | A METHOD FOR DETECTION OF WHOLE TRANSCRIPTOME IN SINGLE CELLS | PARISI, JESSICA DANIELLE | 126d overdue |
| Art Unit | Apps |
|---|---|
| 1684 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17996196 | A METHOD FOR DETECTION OF WHOLE TRANSCRIPTOME IN SINGLE CELLS | PARISI, JESSICA DANIELLE | 1684 | §102§112 | Final Rejection | 126d overdue | Pending | Oct 13, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSingleron (Nanjing) Biotechnologies Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jessica Danielle Parisi has the most, with 1 of Singleron (Nanjing) Biotechnologies Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
